6-methoxy-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyrimidin-4-amine;N-[4-(2-methyl-7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyrimidin-2-amine;N-[4-(3-methyl-7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyrimidin-2-amine;5-methyl-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]-1,3-thiazole-2-carboxamide;N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]-5-(trifluoromethyl)pyridin-2-amine

C116H137F3N28O12S — CID 158877392

IUPAC6-methoxy-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyrimidin-4-amine;N-[4-(2-methyl-7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyrimidin-2-amine;N-[4-(3-methyl-7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyrimidin-2-amine;5-methyl-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]-1,3-thiazole-2-carboxamide;N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]-5-(trifluoromethyl)pyridin-2-amine
SMILESCOc1cc(NC2CCC(Oc3cc(N4CCOCC4)cc4nccnc34)CC2)ncn1.Cc1cnc(C(=O)NC2CCC(Oc3cc(N4CCOCC4)cc4nccnc34)CC2)s1.Cc1cnc2c(OC3CCC(Nc4ncccn4)CC3)cc(N3CCOCC3)cc2n1.Cc1cnc2cc(N3CCOCC3)cc(OC3CCC(Nc4ncccn4)CC3)c2n1.FC(F)(F)c1ccc(NC2CCC(Oc3cc(N4CCOCC4)cc4nccnc34)CC2)nc1
InChIInChI=1S/C24H26F3N5O2.C23H28N6O3.2C23H28N6O2.C23H27N5O3S/c25-24(26,27)16-1-6-22(30-15-16)31-17-2-4-19(5-3-17)34-21-14-18(32-9-11-33-12-10-32)13-20-23(21)29-8-7-28-20;1-30-22-14-21(26-15-27-22)28-16-2-4-18(5-3-16)32-20-13-17(29-8-10-31-11-9-29)12-19-23(20)25-7-6-24-19;1-16-15-26-22-20(27-16)13-18(29-9-11-30-12-10-29)14-21(22)31-19-5-3-17(4-6-19)28-23-24-7-2-8-25-23;1-16-15-26-20-13-18(29-9-11-30-12-10-29)14-21(22(20)27-16)31-19-5-3-17(4-6-19)28-23-24-7-2-8-25-23;1-15-14-26-23(32-15)22(29)27-16-2-4-18(5-3-16)31-20-13-17(28-8-10-30-11-9-28)12-19-21(20)25-7-6-24-19/h1,6-8,13-15,17,19H,2-5,9-12H2,(H,30,31);6-7,12-16,18H,2-5,8-11H2,1H3,(H,26,27,28);2*2,7-8,13-15,17,19H,3-6,9-12H2,1H3,(H,24,25,28);6-7,12-14,16,18H,2-5,8-11H2,1H3,(H,27,29)
InChIKeyJCPKAWLANPWWMX-UHFFFAOYSA-N
MW2204.62 g/mol
LogP17.83
Rot. Bonds26

About 6-methoxy-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyrimidin-4-amine;N-[4-(2-methyl-7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyrimidin-2-amine;N-[4-(3-methyl-7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyrimidin-2-amine;5-methyl-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]-1,3-thiazole-2-carboxamide;N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]-5-(trifluoromethyl)pyridin-2-amine

6-methoxy-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyrimidin-4-amine;N-[4-(2-methyl-7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyrimidin-2-amine;N-[4-(3-methyl-7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyrimidin-2-amine;5-methyl-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]-1,3-thiazole-2-carboxamide;N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]-5-(trifluoromethyl)pyridin-2-amine (PubChem CID 158877392) has the molecular formula C116H137F3N28O12S and a molecular weight of 2204.62 g/mol. Its IUPAC name is 6-methoxy-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyrimidin-4-amine;N-[4-(2-methyl-7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyrimidin-2-amine;N-[4-(3-methyl-7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyrimidin-2-amine;5-methyl-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]-1,3-thiazole-2-carboxamide;N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]-5-(trifluoromethyl)pyridin-2-amine.

Molecular Properties

Compound Name6-methoxy-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyrimidin-4-amine;N-[4-(2-methyl-7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyrimidin-2-amine;N-[4-(3-methyl-7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyrimidin-2-amine;5-methyl-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]-1,3-thiazole-2-carboxamide;N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]-5-(trifluoromethyl)pyridin-2-amine
PubChem CID158877392
Molecular FormulaC116H137F3N28O12S
Molecular Weight2204.62 g/mol
Exact Mass2203.06
IUPAC Name6-methoxy-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyrimidin-4-amine;N-[4-(2-methyl-7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyrimidin-2-amine;N-[4-(3-methyl-7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyrimidin-2-amine;5-methyl-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]-1,3-thiazole-2-carboxamide;N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]-5-(trifluoromethyl)pyridin-2-amine
SMILESCOc1cc(NC2CCC(Oc3cc(N4CCOCC4)cc4nccnc34)CC2)ncn1.Cc1cnc(C(=O)NC2CCC(Oc3cc(N4CCOCC4)cc4nccnc34)CC2)s1.Cc1cnc2c(OC3CCC(Nc4ncccn4)CC3)cc(N3CCOCC3)cc2n1.Cc1cnc2cc(N3CCOCC3)cc(OC3CCC(Nc4ncccn4)CC3)c2n1.FC(F)(F)c1ccc(NC2CCC(Oc3cc(N4CCOCC4)cc4nccnc34)CC2)nc1
InChIInChI=1S/C24H26F3N5O2.C23H28N6O3.2C23H28N6O2.C23H27N5O3S/c25-24(26,27)16-1-6-22(30-15-16)31-17-2-4-19(5-3-17)34-21-14-18(32-9-11-33-12-10-32)13-20-23(21)29-8-7-28-20;1-30-22-14-21(26-15-27-22)28-16-2-4-18(5-3-16)32-20-13-17(29-8-10-31-11-9-29)12-19-23(20)25-7-6-24-19;1-16-15-26-22-20(27-16)13-18(29-9-11-30-12-10-29)14-21(22)31-19-5-3-17(4-6-19)28-23-24-7-2-8-25-23;1-16-15-26-20-13-18(29-9-11-30-12-10-29)14-21(22(20)27-16)31-19-5-3-17(4-6-19)28-23-24-7-2-8-25-23;1-15-14-26-23(32-15)22(29)27-16-2-4-18(5-3-16)31-20-13-17(28-8-10-30-11-9-28)12-19-21(20)25-7-6-24-19/h1,6-8,13-15,17,19H,2-5,9-12H2,(H,30,31);6-7,12-16,18H,2-5,8-11H2,1H3,(H,26,27,28);2*2,7-8,13-15,17,19H,3-6,9-12H2,1H3,(H,24,25,28);6-7,12-14,16,18H,2-5,8-11H2,1H3,(H,27,29)
InChIKeyJCPKAWLANPWWMX-UHFFFAOYSA-N
XLogP17.83
TPSA426.97 Ų
H-Bond Donors5
H-Bond Acceptors40
Rotatable Bonds26
Heavy Atoms160
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5002204.62
LogP ≤ 517.83
H-Bond Donors ≤ 55
H-Bond Acceptors ≤ 1040

Analyze 6-methoxy-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyrimidin-4-amine;N-[4-(2-methyl-7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyrimidin-2-amine;N-[4-(3-methyl-7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyrimidin-2-amine;5-methyl-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]-1,3-thiazole-2-carboxamide;N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]-5-(trifluoromethyl)pyridin-2-amine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 6-methoxy-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyrimidin-4-amine;N-[4-(2-methyl-7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyrimidin-2-amine;N-[4-(3-methyl-7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyrimidin-2-amine;5-methyl-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]-1,3-thiazole-2-carboxamide;N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]-5-(trifluoromethyl)pyridin-2-amine?
The IUPAC name of 6-methoxy-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyrimidin-4-amine;N-[4-(2-methyl-7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyrimidin-2-amine;N-[4-(3-methyl-7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyrimidin-2-amine;5-methyl-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]-1,3-thiazole-2-carboxamide;N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]-5-(trifluoromethyl)pyridin-2-amine (CID 158877392) is 6-methoxy-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyrimidin-4-amine;N-[4-(2-methyl-7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyrimidin-2-amine;N-[4-(3-methyl-7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyrimidin-2-amine;5-methyl-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]-1,3-thiazole-2-carboxamide;N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]-5-(trifluoromethyl)pyridin-2-amine.
What is the SMILES notation for 6-methoxy-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyrimidin-4-amine;N-[4-(2-methyl-7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyrimidin-2-amine;N-[4-(3-methyl-7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyrimidin-2-amine;5-methyl-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]-1,3-thiazole-2-carboxamide;N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]-5-(trifluoromethyl)pyridin-2-amine?
The canonical SMILES for 6-methoxy-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyrimidin-4-amine;N-[4-(2-methyl-7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyrimidin-2-amine;N-[4-(3-methyl-7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyrimidin-2-amine;5-methyl-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]-1,3-thiazole-2-carboxamide;N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]-5-(trifluoromethyl)pyridin-2-amine is COc1cc(NC2CCC(Oc3cc(N4CCOCC4)cc4nccnc34)CC2)ncn1.Cc1cnc(C(=O)NC2CCC(Oc3cc(N4CCOCC4)cc4nccnc34)CC2)s1.Cc1cnc2c(OC3CCC(Nc4ncccn4)CC3)cc(N3CCOCC3)cc2n1.Cc1cnc2cc(N3CCOCC3)cc(OC3CCC(Nc4ncccn4)CC3)c2n1.FC(F)(F)c1ccc(NC2CCC(Oc3cc(N4CCOCC4)cc4nccnc34)CC2)nc1.
What is the InChIKey of 6-methoxy-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyrimidin-4-amine;N-[4-(2-methyl-7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyrimidin-2-amine;N-[4-(3-methyl-7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyrimidin-2-amine;5-methyl-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]-1,3-thiazole-2-carboxamide;N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]-5-(trifluoromethyl)pyridin-2-amine?
The InChIKey is JCPKAWLANPWWMX-UHFFFAOYSA-N. The full InChI is InChI=1S/C24H26F3N5O2.C23H28N6O3.2C23H28N6O2.C23H27N5O3S/c25-24(26,27)16-1-6-22(30-15-16)31-17-2-4-19(5-3-17)34-21-14-18(32-9-11-33-12-10-32)13-20-23(21)29-8-7-28-20;1-30-22-14-21(26-15-27-22)28-16-2-4-18(5-3-16)32-20-13-17(29-8-10-31-11-9-29)12-19-23(20)25-7-6-24-19;1-16-15-26-22-20(27-16)13-18(29-9-11-30-12-10-29)14-21(22)31-19-5-3-17(4-6-19)28-23-24-7-2-8-25-23;1-16-15-26-20-13-18(29-9-11-30-12-10-29)14-21(22(20)27-16)31-19-5-3-17(4-6-19)28-23-24-7-2-8-25-23;1-15-14-26-23(32-15)22(29)27-16-2-4-18(5-3-16)31-20-13-17(28-8-10-30-11-9-28)12-19-21(20)25-7-6-24-19/h1,6-8,13-15,17,19H,2-5,9-12H2,(H,30,31);6-7,12-16,18H,2-5,8-11H2,1H3,(H,26,27,28);2*2,7-8,13-15,17,19H,3-6,9-12H2,1H3,(H,24,25,28);6-7,12-14,16,18H,2-5,8-11H2,1H3,(H,27,29).
What are the key properties of 6-methoxy-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyrimidin-4-amine;N-[4-(2-methyl-7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyrimidin-2-amine;N-[4-(3-methyl-7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyrimidin-2-amine;5-methyl-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]-1,3-thiazole-2-carboxamide;N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]-5-(trifluoromethyl)pyridin-2-amine?
6-methoxy-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyrimidin-4-amine;N-[4-(2-methyl-7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyrimidin-2-amine;N-[4-(3-methyl-7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyrimidin-2-amine;5-methyl-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]-1,3-thiazole-2-carboxamide;N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]-5-(trifluoromethyl)pyridin-2-amine has a molecular weight of 2204.62 g/mol, XLogP of 17.83, 26 rotatable bonds, 5 hydrogen bond donors, and 40 hydrogen bond acceptors.
Where does this data come from?
All data for 6-methoxy-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyrimidin-4-amine;N-[4-(2-methyl-7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyrimidin-2-amine;N-[4-(3-methyl-7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]pyrimidin-2-amine;5-methyl-N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]-1,3-thiazole-2-carboxamide;N-[4-(7-morpholin-4-ylquinoxalin-5-yl)oxycyclohexyl]-5-(trifluoromethyl)pyridin-2-amine is sourced from PubChem (CID 158877392), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).